232 related articles for article (PubMed ID: 27189014)
21. Risk for recurrence of symptomatic upper-extremity deep vein thrombosis in patients without cancer: Analysis of three RIETE cohorts.
Núñez Fernández MJ; Padín Paz EM; Vázquez Temprano N; Nieto Rodríguez JA; Marchena Yglesias PJ; Imbalzano E; Montenegro AC; Fernández Jiménez B; Rivera A; Espitia O; Monreal M
Vasc Med; 2023 Aug; 28(4):324-330. PubMed ID: 37272085
[TBL] [Abstract][Full Text] [Related]
22. Upper extremity deep vein thrombosis treated with direct oral anticoagulants: a multi-center real world experience.
Porfidia A; Agostini F; Giarretta I; Tonello D; Pastori D; Pignatelli P; Santoliquido A; Sartori M; Lessiani G; Visonà A; Donadini MP; Pola R
J Thromb Thrombolysis; 2020 Aug; 50(2):355-360. PubMed ID: 32008208
[TBL] [Abstract][Full Text] [Related]
23. Outcome of central venous catheter associated upper extremity deep vein thrombosis in cancer patients.
Delluc A; Le Gal G; Scarvelis D; Carrier M
Thromb Res; 2015 Feb; 135(2):298-302. PubMed ID: 25491940
[TBL] [Abstract][Full Text] [Related]
24. Rivaroxaban in the treatment of upper extremity deep vein thrombosis: A single-center experience and review of the literature.
Schastlivtsev I; Lobastov K; Tsaplin S; Kanzafarova I; Barinov V; Laberko L; Rodoman G; Zhuravlev S
Thromb Res; 2019 Sep; 181():24-28. PubMed ID: 31326717
[TBL] [Abstract][Full Text] [Related]
25. A review of upper extremity deep vein thrombosis.
Khan O; Marmaro A; Cohen DA
Postgrad Med; 2021 Aug; 133(sup1):3-10. PubMed ID: 33618595
[TBL] [Abstract][Full Text] [Related]
26. Upper Extremity Deep Venous Thrombosis Risk Factors, Associated Morbidity and Mortality in Trauma Patients.
Walusimbi M; Dossa AY; Faryar K; Markert RJ; McCarthy MC
World J Surg; 2022 Mar; 46(3):561-567. PubMed ID: 34981151
[TBL] [Abstract][Full Text] [Related]
27. Management of catheter-associated upper extremity deep venous thrombosis.
Crawford JD; Liem TK; Moneta GL
J Vasc Surg Venous Lymphat Disord; 2016 Jul; 4(3):375-9. PubMed ID: 27318061
[TBL] [Abstract][Full Text] [Related]
28. Upper-extremity deep vein thrombosis: a prospective registry of 592 patients.
Joffe HV; Kucher N; Tapson VF; Goldhaber SZ;
Circulation; 2004 Sep; 110(12):1605-11. PubMed ID: 15353493
[TBL] [Abstract][Full Text] [Related]
29. Deep venous thrombosis of the upper extremity. A review.
Klitfod L; Broholm R; Baekgaard N
Int Angiol; 2013 Oct; 32(5):447-52. PubMed ID: 23903301
[TBL] [Abstract][Full Text] [Related]
30. Single-center experience with catheter-directed thrombolysis and balloon angioplasty for acute upper-extremity deep vein thrombosis: a case series study.
Jenab Y; Tofighi S; Ayati A; Rezvanimehr A; Moosavi NS; Jalaie H; Barbati ME
BMC Cardiovasc Disord; 2023 Jul; 23(1):351. PubMed ID: 37460994
[TBL] [Abstract][Full Text] [Related]
31. Prophylaxis of catheter-related deep vein thrombosis in cancer patients with low-dose warfarin, low molecular weight heparin, or control: a randomized, controlled, phase III study.
Lavau-Denes S; Lacroix P; Maubon A; Preux PM; Genet D; Vénat-Bouvet L; Labourey JL; Martin J; Slaouti P; Tubiana-Mathieu N
Cancer Chemother Pharmacol; 2013 Jul; 72(1):65-73. PubMed ID: 23636449
[TBL] [Abstract][Full Text] [Related]
32. Upper-extremity deep venous thrombosis after whole blood donation: report of three cases from a single blood center.
Newman B; Rajpurkar M; Ozgonenel B; Lal A; Kuriakose P
Transfusion; 2015 Jun; 55(6):1290-3. PubMed ID: 25712335
[TBL] [Abstract][Full Text] [Related]
33. Low-dose apixaban or rivaroxaban as secondary prophylaxis of upper extremity deep vein thrombosis.
Ligia S; Musiu P; Serrao A; Santoro C; Taglietti A; Capriata M; Faccini A; Molinari MC; Baldacci E; Chistolini A
J Thromb Thrombolysis; 2023 Aug; 56(2):323-326. PubMed ID: 37341894
[TBL] [Abstract][Full Text] [Related]
34. Upper extremities deep vein thrombosis treated with oral direct anticoagulants: A prospective cohort study.
Vedovati MC; Tratar G; Mavri A; Mazzetti M; Salazar Rosa V; Pierpaoli L; Cotugno M; Agnelli G; Becattini C
Int J Cardiol; 2021 Sep; 339():158-163. PubMed ID: 34245794
[TBL] [Abstract][Full Text] [Related]
35. Evaluating warfarin management by pharmacists in a community teaching hospital.
Chilipko AA; Norwood DK
Consult Pharm; 2014 Feb; 29(2):95-103. PubMed ID: 24513419
[TBL] [Abstract][Full Text] [Related]
36. Diagnosis and management of upper extremity deep-vein thrombosis in adults.
Grant JD; Stevens SM; Woller SC; Lee EW; Kee ST; Liu DM; Lohan DG; Elliott CG
Thromb Haemost; 2012 Dec; 108(6):1097-108. PubMed ID: 23093319
[TBL] [Abstract][Full Text] [Related]
37. [Two Cases of Catheter-Related Venous Thrombosis Treated with Direct Oral Anticoagulants(DOAC)].
Terasawa T; Fukuda K; Yanai A; Matsuo C
Gan To Kagaku Ryoho; 2023 Sep; 50(9):993-996. PubMed ID: 37800295
[TBL] [Abstract][Full Text] [Related]
38. Post-thrombotic syndrome and recurrent thromboembolism in patients with upper extremity deep vein thrombosis: A systematic review and meta-analysis.
Thiyagarajah K; Ellingwood L; Endres K; Hegazi A; Radford J; Iansavitchene A; Lazo-Langner A
Thromb Res; 2019 Feb; 174():34-39. PubMed ID: 30553163
[TBL] [Abstract][Full Text] [Related]
39. Upper extremity deep vein thrombosis in COVID-19: Incidence and correlated risk factors in a cohort of non-ICU patients.
Mumoli N; Dentali F; Conte G; Colombo A; Capra R; Porta C; Rotiroti G; Zuretti F; Cei M; Tangianu F; Evangelista I; Vitale J; Mazzone A; Giarretta I
PLoS One; 2022; 17(1):e0262522. PubMed ID: 35020777
[TBL] [Abstract][Full Text] [Related]
40. The Association Between PICC Use and Venous Thromboembolism in Upper and Lower Extremities.
Greene MT; Flanders SA; Woller SC; Bernstein SJ; Chopra V
Am J Med; 2015 Sep; 128(9):986-93.e1. PubMed ID: 25940453
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
